Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1

Update: 2024-04-25

Description

In this first episode, join our clinical development and market access experts who discuss the role of biomarker research, discovery, and patient access in advancing precision oncology to date. Biomarkers have been central to improving patient outcomes and guiding treatment guidelines in lung, breast, and blood cancers. With that backdrop, our experts discuss the role of large-scale data sets and real-world evidence in furthering precision oncology research and improving patient outcomes in more types of cancer.

Dr. Gwyn Bebb, Senior Vice President and Global Therapeutic Head of Oncology

Wyatt Gotbetter, Senior Vice President Worldwide, Access Consulting

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Navigating market access in neuroscience: Challenges and strategies

2024-10-1626:22

Leveraging people, processes and technology to deliver for biotech

2024-10-0122:02

De-risking Drug Development | Episode 5: Expand the use and value of your product over time

2024-09-2534:38

De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval

2024-09-2533:53

Podcast: Accelerated approvals – what’s next, confirmatory trials, access, and pricing

2024-08-0512:51

De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept

2024-07-1639:29

Enabling Successful Sites Ep. 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

2024-06-2827:09

Enabling Successful Sites Ep. 3: Taking the complexity out of oncology trials

2024-06-2826:40

De-risking Drug Development | Episode 2: Focus on safety and efficacy and prove quickly that your product works

2024-06-1938:13

De-risking Drug Development | Episode 1: How to drive value in pre-clinical development

2024-05-2323:37

Enabling Successful Sites, Episode 1: Solving Site Feasibility and Start-Up Challenges

2024-05-1016:40

Rare Endpoints: Delivering on Unmet Patient Needs

2024-05-0711:19

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 3

2024-04-2513:22

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 2

2024-04-2513:27

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1

2024-04-2520:51

CAR-T boxed warnings: What comes next?

2024-03-0633:57

Preparing for a Cell and Gene Future | Episode 1: Looking Back at 2023 Achievements

2024-01-1017:41

Three trends impacting market access in the EU

2024-01-0413:23

How can we advance fair and ethical reimbursement for patients?

2023-11-2111:21

Beyond the Binary: Navigating Gender Diversity in Clinical Research

2023-06-0827:13

00:00

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1

#box-pro-ellipsis-173243687963046{-webkit-line-clamp:2;}Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1

PAREXEL

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1